Explore more publications!

French Guiana Tech World: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on French Guiana Tech World.

Press releases published on November 13, 2025

“LEQEMBI®” (lecanemab) IV Maintenance Dosing for the Treatment of Early Alzheimer’s Disease Approved in the United Kingdom
Data Storage Corporation Postpones 2025 Third Quarter Business Update Conference Call
Digital Therapeutics Endometriosis Market to Reach US $3.8 Billion by 2029 | The Business Research Company
Digital Therapeutics For Atopic Dermatitis Market Projected to Reach $1.24 Billion with 21.3% CAGR by 2029
Global Digital Therapeutics For Fibromyalgia Market to Reach $2.53 Billion at a Steady 20.9% CAGR by 2029
Digital Therapeutics for Migraine Market to Exceed US $3.91 Billion by 2029, 23.3% CAGR: The Business Research Company
Continuous Lactate Monitor Sensor Market to Reach USD $2.99 Billion by 2029 at 15.3% CAGR
Digi Power X Achieves Positive Net Earnings for Q3 2025 and Reports Strong Balance Sheet to Support 2026 AI Infrastructure Development Plan
Cricket Market: Future Demand and Top Key Players Analysis | 2029
Crypto-Powered Remittances Market Size, Share, Competitive Landscape and Trend Analysis Report
Curtains Market - Opportunities, Share, Growth and Competitive Analysis and Forecast 2029
Customer Data Integration Market Size, Share & Drivers Analysis Report By Product
Data Availability Layer Market Size Worth $4.39 Billion by 2029 - Exclusive Report by The Business Research Company
Data Residency Services Market Anticipated to Grow at 16.1% CAGR Through 2029: Industry Report
Data Sovereignty Cloud Market Trends and Analysis by Application, Vertical, Region, and Segment Forecast to 2029
Decentralized Trial Wearable Industry Report: Competitive Landscape and Future Prospects
Comprehensive Report on the Decentralized Trial Wearable Kit Market: Opportunities and Challenges
Dental Hygiene Reminder App Industry Analysis Report 2025: Key Trends, Drivers, and Forecast Insights
Aptose Reports Third Quarter 2025 Results
Eupraxia Pharmaceuticals Reports Additional 52-week Follow-up Data from the RESOLVE Trial in Eosinophilic Esophagitis (EoE) Demonstrating Consistent Results after Dosing with EP-104GI

Share us

on your social networks:
AGPs

Get the latest news on this topic.

SIGN UP FOR FREE TODAY

No Thanks

By signing to this email alert, you
agree to our Terms & Conditions